Diagnostics & Research Industry Returns
Track and compare the best performing companies in the Diagnostics & Research industry. Find top stocks ranked by their compound annual growth rate (CAGR).
Top Performer (5Y)
Natera, Inc.
Industry Rank
#139
1 Month Trend
18.49%
Positive Returns
31%
| # | Name | Price | 1m | 3m | 5Y CAGR | Market Cap | Country |
|---|---|---|---|---|---|---|---|
| 1 | N NTRA Natera, Inc. | $163.76 | 0.73% | 16.42% | 31.78% | $20.9B | US |
| 2 | M MEDP Medpace Holdings, Inc. | $296.50 | -1.43% | -10.91% | 25.89% | $8.8B | US |
| 3 | R RDNT RadNet, Inc. | $58.65 | 4.03% | 16.58% | 25.84% | $4.5B | US |
| 4 | I IDXX IDEXX Laboratories, Inc. | $524.91 | 7.13% | 22.04% | 11.14% | $41.8B | US |
| 5 | W WAT Waters Corporation | $351.17 | 0.08% | -10.64% | 11.03% | $21.3B | US |
| 6 | L LH Labcorp Holdings Inc. | $253.97 | 2.09% | 0.37% | 10.97% | $20.9B | US |
| 7 | D DGX Quest Diagnostics Incorporated | $174.34 | -0.89% | -0.21% | 10.51% | $19.9B | US |
| 8 | M MTD Mettler-Toledo International Inc. | $1.2K | 7.51% | -8.30% | 6.90% | $24.0B | US |
| 9 | A A Agilent Technologies, Inc. | $115.80 | 6.53% | -8.41% | 5.82% | $32.3B | US |
| 10 | D DHR Danaher Corporation | $196.02 | 0.62% | -7.43% | 5.64% | $140.2B | US |
| 11 | F FLGT Fulgent Genetics, Inc. | $21.43 | 15.46% | 15.28% | 5.17% | $645.1M | US |
| 12 | T TMO Thermo Fisher Scientific Inc. | $401.90 | -2.16% | -24.35% | 3.06% | $156.1B | US |
| 13 | Q QGEN Qiagen N.V. | $45.48 | 7.87% | 14.42% | 1.24% | $9.3B | US |
| 14 | V VCYT Veracyte, Inc. | $27.46 | -12.02% | -14.24% | 0.87% | $2.3B | US |
| 15 | I IQV IQVIA Holdings Inc. | $152.32 | -0.63% | -20.51% | 0.31% | $24.7B | US |
| 16 | R RVTY Revvity, Inc. | $91.97 | -1.00% | -21.71% | -2.46% | $11.1B | US |
| 17 | I ICLR ICON Public Limited Company | $139.11 | 0.45% | -25.43% | -3.05% | $10.4B | US |
| 18 | T TWST Twist Bioscience Corporation | $31.57 | -3.19% | -19.93% | -3.41% | $1.8B | US |
| 19 | C CRL Charles River Laboratories International, Inc. | $144.70 | 2.36% | -17.75% | -4.80% | $6.9B | US |
| 20 | E EXAS Exact Sciences Corporation | $54.87 | 3.41% | 16.60% | -9.53% | $10.7B | US |
| 21 | G GH Guardant Health, Inc. | $48.06 | 15.31% | 22.23% | -9.76% | $5.0B | US |
| 22 | F FONR FONAR Corporation | $14.48 | 15.42% | 2.80% | -10.42% | $84.8M | US |
| 23 | C CDNA CareDx, Inc | $19.52 | 26.84% | 3.17% | -10.69% | $988.3M | US |
| 24 | X XGN Exagen Inc. | $7.25 | 17.69% | 124.46% | -10.72% | $134.6M | US |
| 25 | N NOTV Inotiv, Inc. | $2.69 | 21.17% | 2.67% | -11.91% | $77.6M | US |
| 26 | O OPK OPKO Health, Inc. | $1.36 | 7.94% | -28.42% | -12.82% | $1.1B | US |
| 27 | C CSTL Castle Biosciences, Inc. | $17.60 | 2.27% | -12.91% | -14.10% | $473.4M | US |
| 28 | P PRPO Precipio, Inc. | $11.20 | 73.56% | 61.73% | -16.02% | $11.7M | US |
| 29 | P PSNL Personalis, Inc. | $5.21 | 0.97% | 25.85% | -17.35% | $439.4M | US |
| 30 | M MYGN Myriad Genetics, Inc. | $5.09 | 26.30% | -50.00% | -20.96% | $399.6M | US |
| 31 | P PRPH ProPhase Labs, Inc. | $0.36 | 19.33% | -14.76% | -22.30% | $14.7M | US |
| 32 | N NEO NeoGenomics, Inc. | $7.42 | -8.73% | -26.53% | -23.25% | $1.1B | US |
| 33 | I ILMN Illumina, Inc. | $82.66 | 3.87% | -4.57% | -25.04% | $13.1B | US |
| 34 | N NEOG Neogen Corporation | $5.21 | -13.02% | -49.90% | -32.09% | $1.4B | US |
| 35 | S STRR Star Equity Holdings, Inc. | $2.13 | -9.57% | -5.97% | -32.46% | $7.6M | US |
| 36 | O OCX OncoCyte Corporation | $2.97 | 4.58% | -23.85% | -43.12% | $79.8M | US |
| 37 | X XWEL XWELL, Inc. | $0.95 | 10.47% | -8.65% | -62.88% | $4.9M | US |
| 38 | A APDN Applied DNA Sciences, Inc. | $5.37 | 531.76% | -17.38% | -76.74% | $4.2M | US |
| 39 | A ATLN Atlantic International Corp. | $2.41 | -19.67% | -32.49% | - | $171.6M | US |
| 40 | B BDSX Biodesix, Inc. | $0.30 | -12.96% | -64.86% | - | $43.0M | US |
| 41 | B BIAF bioAffinity Technologies, Inc. | $0.28 | 40.69% | -23.60% | - | $3.9M | US |
| 42 | B BNR Burning Rock Biotech Limited | $2.90 | 20.83% | -48.76% | - | $30.7M | US |
| 43 | G GRAL GRAIL, Inc. | $38.36 | 6.26% | 16.67% | - | $1.3B | US |
| 44 | I ISPC iSpecimen Inc. | $1.26 | 10.53% | -10.64% | - | $2.9M | US |
| 45 | M MDXH MDxHealth SA | $2.07 | 14.36% | 38.93% | - | $101.0M | US |
| 46 | M MYNZ Mainz Biomed N.V. | $2.08 | -18.63% | -63.01% | - | $6.7M | US |
| 47 | P PRE Prenetics Global Limited | $8.32 | 60.40% | 75.30% | - | $86.7M | US |
| 48 | S SHC Sotera Health Company | $12.30 | -7.03% | 1.15% | - | $3.6B | US |
| 49 | W WGS GeneDx Holdings Corp. | $72.07 | 27.87% | -26.47% | - | $2.0B | US |
Industry Analysis
The Diagnostics & Research industry consists of 49 companies tracked by MultiMarketCap.com, with a combined market capitalization of $600.1B.
The average 5y-year Compound Annual Growth Rate (CAGR) for the industry is -6.53%, which indicates challenges within this sector. Only 31% of companies in this industry have shown positive returns over this period.
The top performer in the Diagnostics & Research industry is Natera, Inc. (NTRA) with a 5y-year CAGR of 31.78%. On the other end, Applied DNA Sciences, Inc. (APDN) has shown the lowest returns with a CAGR of -76.74%.
In terms of recent performance, the industry has shown an average 1-month return of 18.49%, indicating a positive short-term trend.
Compared to other industries, the Diagnostics & Research sector ranks #139 out of 157 industries tracked by MultiMarketCap.com in terms of 5y-year returns.